Aehr Net Receivables vs Common Stock Analysis

AEHR Stock

USD 14.25 0.93 6.98%

Aehr Test financial indicator trend analysis is way more than just evaluating Aehr Test Systems prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aehr Test Systems is a good investment. Please check the relationship between Aehr Test Net Receivables and its Common Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Net Receivables vs Common Stock

Net Receivables vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aehr Test Systems Net Receivables account and Common Stock. At this time, the significance of the direction appears to have strong relationship.

The correlation between Aehr Test's Net Receivables and Common Stock is 0.62. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Common Stock in the same time period over historical financial statements of Aehr Test Systems, assuming nothing else is changed. The correlation between historical values of Aehr Test's Net Receivables and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Aehr Test Systems are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Net Receivables i.e., Aehr Test's Net Receivables and Common Stock go up and down completely randomly.

Correlation Coefficient

0.62

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Net Receivables

Common Stock

Most indicators from Aehr Test's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aehr Test Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

At this time, Aehr Test's Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 12/22/2024, Enterprise Value Multiple is likely to grow to 26.50, though Tax Provision is likely to grow to (19.7 M).

	2021	2022	2023	2024 (projected)
Gross Profit	23.7M	32.7M	32.5M	34.2M
Total Revenue	50.8M	65.0M	66.2M	69.5M

Gross Profit Total Revenue

Aehr Test fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Current Deferred Revenue	Common Stock Total Equity	Short Term Investments
Total Assets		0.29	0.78	0.46	1.0	0.95	-0.95	0.45	0.8	0.97	0.92	0.17	0.97	0.65	0.76	0.57	0.98	0.25	0.84	0.53	0.96	0.99	-0.12	-0.21	0.7	0.19
Short Long Term Debt Total	0.29		0.32	0.43	0.23	0.39	-0.15	0.02	0.35	0.25	0.26	0.12	0.3	0.15	0.3	0.63	0.27	0.28	0.26	0.7	0.33	0.29	0.16	0.07	0.39	0.32
Other Current Liab	0.78	0.32		0.72	0.75	0.79	-0.63	0.7	0.89	0.66	0.67	0.61	0.72	0.75	0.4	0.34	0.78	0.63	0.45	0.65	0.75	0.79	0.1	-0.28	0.31	0.69
Total Current Liabilities	0.46	0.43	0.72		0.41	0.46	-0.39	0.32	0.79	0.41	0.2	0.46	0.52	0.79	0.3	0.12	0.38	0.63	0.3	0.86	0.33	0.53	0.38	0.09	0.22	0.77
Total Stockholder Equity	1.0	0.23	0.75	0.41		0.94	-0.96	0.45	0.76	0.97	0.93	0.15	0.96	0.62	0.77	0.54	0.98	0.22	0.85	0.46	0.96	0.98	-0.13	-0.24	0.7	0.14
Property Plant And Equipment Net	0.95	0.39	0.79	0.46	0.94		-0.82	0.42	0.83	0.86	0.89	0.14	0.91	0.64	0.74	0.65	0.95	0.2	0.81	0.58	0.97	0.94	-0.14	-0.27	0.67	0.31
Net Debt	-0.95	-0.15	-0.63	-0.39	-0.96	-0.82		-0.31	-0.67	-0.99	-0.84	-0.04	-0.96	-0.62	-0.8	-0.46	-0.9	-0.18	-0.88	-0.43	-0.86	-0.95	0.15	0.1	-0.74	0.01
Retained Earnings	0.45	0.02	0.7	0.32	0.45	0.42	-0.31		0.42	0.34	0.56	0.8	0.31	0.19	-0.18	0.13	0.53	0.53	-0.09	0.23	0.5	0.4	0.09	-0.35	-0.24	0.44
Accounts Payable	0.8	0.35	0.89	0.79	0.76	0.83	-0.67	0.42		0.7	0.58	0.27	0.81	0.88	0.56	0.45	0.73	0.42	0.63	0.78	0.72	0.84	-0.03	-0.08	0.45	0.68
Cash	0.97	0.25	0.66	0.41	0.97	0.86	-0.99	0.34	0.7		0.87	0.07	0.97	0.59	0.79	0.55	0.93	0.2	0.88	0.48	0.89	0.97	-0.11	-0.11	0.75	0.02
Non Current Assets Total	0.92	0.26	0.67	0.2	0.93	0.89	-0.84	0.56	0.58	0.87		0.24	0.82	0.35	0.62	0.56	0.97	0.2	0.7	0.3	0.97	0.87	-0.11	-0.39	0.59	0.0
Non Currrent Assets Other	0.17	0.12	0.61	0.46	0.15	0.14	-0.04	0.8	0.27	0.07	0.24		0.03	0.16	-0.25	-0.21	0.24	0.83	-0.27	0.19	0.18	0.14	0.54	-0.42	-0.26	0.53
Cash And Short Term Investments	0.97	0.3	0.72	0.52	0.96	0.91	-0.96	0.31	0.81	0.97	0.82	0.03		0.7	0.81	0.59	0.91	0.17	0.89	0.6	0.89	0.99	-0.16	-0.04	0.73	0.19
Net Receivables	0.65	0.15	0.75	0.79	0.62	0.64	-0.62	0.19	0.88	0.59	0.35	0.16	0.7		0.57	0.19	0.55	0.42	0.61	0.71	0.51	0.72	-0.03	0.0	0.45	0.61
Common Stock Shares Outstanding	0.76	0.3	0.4	0.3	0.77	0.74	-0.8	-0.18	0.56	0.79	0.62	-0.25	0.81	0.57		0.4	0.71	0.01	0.97	0.36	0.7	0.78	-0.01	-0.15	0.96	-0.08
Non Current Liabilities Total	0.57	0.63	0.34	0.12	0.54	0.65	-0.46	0.13	0.45	0.55	0.56	-0.21	0.59	0.19	0.4		0.55	-0.09	0.51	0.57	0.63	0.56	-0.52	0.22	0.43	0.11
Inventory	0.98	0.27	0.78	0.38	0.98	0.95	-0.9	0.53	0.73	0.93	0.97	0.24	0.91	0.55	0.71	0.55		0.25	0.78	0.44	0.98	0.95	-0.1	-0.31	0.64	0.15
Other Current Assets	0.25	0.28	0.63	0.63	0.22	0.2	-0.18	0.53	0.42	0.2	0.2	0.83	0.17	0.42	0.01	-0.09	0.25		-0.03	0.42	0.2	0.25	0.52	-0.31	0.06	0.52
Other Stockholder Equity	0.84	0.26	0.45	0.3	0.85	0.81	-0.88	-0.09	0.63	0.88	0.7	-0.27	0.89	0.61	0.97	0.51	0.78	-0.03		0.41	0.78	0.86	-0.17	-0.07	0.93	-0.07
Total Liab	0.53	0.7	0.65	0.86	0.46	0.58	-0.43	0.23	0.78	0.48	0.3	0.19	0.6	0.71	0.36	0.57	0.44	0.42	0.41		0.45	0.58	0.01	0.26	0.32	0.67
Property Plant And Equipment Gross	0.96	0.33	0.75	0.33	0.96	0.97	-0.86	0.5	0.72	0.89	0.97	0.18	0.89	0.51	0.7	0.63	0.98	0.2	0.78	0.45		0.93	-0.13	-0.34	0.65	0.16
Total Current Assets	0.99	0.29	0.79	0.53	0.98	0.94	-0.95	0.4	0.84	0.97	0.87	0.14	0.99	0.72	0.78	0.56	0.95	0.25	0.86	0.58	0.93		-0.12	-0.14	0.7	0.25
Short Term Debt	-0.12	0.16	0.1	0.38	-0.13	-0.14	0.15	0.09	-0.03	-0.11	-0.11	0.54	-0.16	-0.03	-0.01	-0.52	-0.1	0.52	-0.17	0.01	-0.13	-0.12		-0.42	0.02	0.16
Current Deferred Revenue	-0.21	0.07	-0.28	0.09	-0.24	-0.27	0.1	-0.35	-0.08	-0.11	-0.39	-0.42	-0.04	0.0	-0.15	0.22	-0.31	-0.31	-0.07	0.26	-0.34	-0.14	-0.42		-0.14	0.03
Common Stock Total Equity	0.7	0.39	0.31	0.22	0.7	0.67	-0.74	-0.24	0.45	0.75	0.59	-0.26	0.73	0.45	0.96	0.43	0.64	0.06	0.93	0.32	0.65	0.7	0.02	-0.14		-0.17
Short Term Investments	0.19	0.32	0.69	0.77	0.14	0.31	0.01	0.44	0.68	0.02	0.0	0.53	0.19	0.61	-0.08	0.11	0.15	0.52	-0.07	0.67	0.16	0.25	0.16	0.03	-0.17

Click cells to compare fundamentals

Aehr Test Account Relationship Matchups

Aehr Test fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	20.6M	21.7M	62.3M	98.1M	127.9M	134.3M
Other Current Liab	1.4M	1.4M	2.7M	4.8M	4.1M	4.4M
Total Current Liabilities	3.9M	9.1M	11.0M	16.3M	10.5M	7.0M
Total Stockholder Equity	14.1M	11.4M	51.0M	75.6M	111.6M	117.2M
Property Plant And Equipment Net	2.8M	2.3M	2.1M	8.9M	9.0M	9.4M
Net Debt	(1.5M)	241K	(30.5M)	(23.8M)	(43.0M)	(40.8M)
Retained Earnings	(74.3M)	(76.3M)	(66.9M)	(52.3M)	(19.2M)	(20.1M)
Accounts Payable	945K	2.9M	4.2M	9.2M	5.3M	5.6M
Cash	5.4M	4.6M	31.5M	30.1M	49.2M	51.6M
Non Current Assets Total	2.9M	2.5M	2.3M	9.1M	30.1M	31.6M
Non Currrent Assets Other	73K	118K	121K	81K	304K	288.8K
Cash And Short Term Investments	5.4M	4.6M	31.5M	47.9M	49.2M	51.6M
Net Receivables	3.7M	5.2M	12.9M	16.6M	10.0M	5.4M
Common Stock Shares Outstanding	22.9M	23.5M	27.8M	29.2M	29.6M	31.1M
Liabilities And Stockholders Equity	20.6M	21.7M	62.3M	98.1M	127.9M	134.3M
Non Current Liabilities Total	2.7M	1.2M	325K	6.2M	5.8M	6.1M
Inventory	8.0M	8.8M	15.1M	23.9M	37.5M	39.3M
Other Current Assets	512K	1.1M	1.2M	621K	1.2M	899.3K
Other Stockholder Equity	85.9M	87.6M	117.7M	127.8M	130.6M	137.1M
Total Liab	6.5M	10.2M	11.3M	22.5M	16.3M	8.6M
Property Plant And Equipment Gross	2.8M	2.3M	2.1M	8.9M	14.0M	14.7M
Total Current Assets	17.7M	19.2M	60.0M	89.0M	97.8M	102.7M
Accumulated Other Comprehensive Income	2.2M	(28K)	(105K)	(155K)	(158K)	(150.1K)
Current Deferred Revenue	170K	189K	2.4M	2.8M	97K	92.2K
Common Stock Total Equity	221K	227K	231K	237K	272.6K	286.2K
Common Stock	231K	237K	271K	285K	289K	147.2K
Other Liab	22K	148K	113K	72K	64.8K	61.6K
Other Assets	153K	198K	201K	231K	207.9K	380.5K
Property Plant Equipment	2.8M	2.3M	2.1M	8.9M	10.2M	10.7M
Net Tangible Assets	14.1M	11.4M	51.0M	75.6M	86.9M	91.3M
Retained Earnings Total Equity	(66.2M)	(71.5M)	(74.3M)	(76.3M)	(68.7M)	(72.1M)
Capital Surpluse	85.9M	87.6M	117.7M	127.8M	146.9M	85.6M
Deferred Long Term Liab	522K	342K	22K	99K	113.9K	173.1K

Pair Trading with Aehr Test

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.

Moving against Aehr Stock

0.36	AIP	Arteris	Pair Corr
0.34	GFS	Globalfoundries	Pair Corr
0.32	CAN	Canaan Inc	Pair Corr

The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.

The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Aehr Stock Analysis

When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC